In short

Maintenance means staying on treatment at a dose that holds your weight rather than continuing to reduce it. It is increasingly the expected end point rather.

By Alsen Walker · Updated September 22, 2026

Maintenance means staying on treatment at a dose that holds your weight rather than continuing to reduce it. It is increasingly the expected end point rather than an optional extra, because obesity is treated as a chronic condition and regain after stopping is well documented.

Do not reduce your own dose to shift into maintenance. Which dose maintains you is a clinical judgement, and self-reducing affects both accuracy and your insurance authorization. Raise it as a conversation instead.

For how this fits into stopping and maintenance generally, see Stopping a GLP-1: What Happens and How to Plan It.

What maintenance actually is

Continuing treatment with the goal of holding a weight rather than lowering it. For some people that means the same dose they lost weight on; for others a lower one is enough.

There is no single approach, and what suits you depends on your response, your tolerability and what else you are being treated for.

Why it is usually not just stopping

Weight loss lowers your energy requirements, and appetite signals shift in a direction that promotes intake. Both persist after the weight has come off, which is why maintenance without treatment is harder than it sounds.

Studies following people after discontinuation consistently show substantial regain. Maintenance treatment exists because of that finding rather than despite it.

Finding the dose

Usually a matter of adjustment and observation rather than calculation. Your prescriber may hold you where you are, or try a step down and watch what happens over a period.

Weight creeping up at a lower dose is information rather than failure, and it is a reason to review rather than to be discouraged.

Keep measured weights recorded at visits. Maintenance is much easier to manage against a record than against recollection.

The coverage problem

This is where maintenance runs into trouble.

Continuation criteria are frequently written around continued weight loss, which fits awkwardly once the goal is stability. A plan expecting further loss may query a renewal where nothing is changing.

Have your prescriber frame the renewal around maintained benefit: weight held below baseline, comorbidities improved or controlled, and the clinical rationale for continuing. Check your plan’s policy on maintenance specifically before you reach that point.

What has to continue alongside

Protein and resistance training, because muscle preservation matters as much in maintenance as in loss and there is no longer a rapid decline to distract you from it.

Regular movement, which tends to decline quietly once the active phase ends.

Monitoring that is not only the scale, since composition can shift while weight stays flat.

The mental shift

Moving from a phase with visible weekly progress to one where nothing changes is genuinely difficult, and people often describe it as anticlimactic.

Stability is the result, not the absence of one. Weight held below baseline, with better blood pressure, blood sugar or sleep, is the outcome the treatment was for.

Frequently asked questions

Do I stay on the same dose?
Sometimes. Some people maintain on less. A prescriber decision based on your response.

How long does maintenance last?
Often indefinitely, in the way other chronic condition treatments are ongoing.

Will insurance cover maintenance?
Criteria vary and some are written around continued loss. Check your policy before you get there.

What if I gain a little?
A reason to review, not a failure. Small fluctuations are normal.

Can I stop once weight is stable?
Possible, and regain is common. Discuss it rather than assuming stability will hold.

Do I still need protein and training?
Yes. Muscle preservation matters just as much in maintenance.

Alsen Walker is a health writer and researcher at GLP1Hub with five years of experience researching and writing health and medical content. He works in a medical-field role alongside his undergraduate studies. At GLP1Hub he researches GLP-1 weight loss programs, pricing and insurance rules, and checks claims against FDA prescribing information, published clinical trials and official government sources. Alsen is not a physician, and his articles are general information, not medical advice.